Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatment

Simple item page
dc.article.end-page310en
dc.article.start-page302en
dc.citation.doi10.1093/EURJPC/ZWAD332en
dc.contributor.authorR Santosen
dc.contributor.authorA Ruzzaen
dc.contributor.authorBei Wangen
dc.contributor.authorP Maruffen
dc.contributor.authorE et alen
dc.contributor.authorFrederick Raalen
dc.date.accessioned2024-10-08T06:57:35Z
dc.date.available2024-10-08T06:57:35Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2047-4873en
dc.identifier.urihttps://hdl.handle.net/10539/41427
dc.journal.titleEvolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatmenten
dc.journal.volume31en
dc.publisherSAGE PUBLICATIONS LTDen
dc.titleEvolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatmenten
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
3.8 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)